Shares of CareDx (NASDAQ: CDNA) climbed on Friday after the precision medicine diagnostics specialist lifted its full-year sales and earnings forecast.
Image source: Getty Images.
CareDx's revenue surged 52% year over year to $132 million in the second quarter.
Continue reading
Source Fool.com